093); anti-ENA antibodies were positive in 29 (62%) autoimmune polyendocrine syndrome–positive and 113 (62%) autoimmune polyendocrine syndrome–negative patients (P = 0.938); aPL were positive for 20 (43%) autoimmune polyendocrine syndrome–positive and 92 (50%) autoimmune polyendocrine syndrome–negative patients (P = 0.362); the LA test was positive for 9 (19%) autoimmune polyendocrine syndrome–positive and 45 (25%) autoimmune polyendocrine syndrome–negative patients (P = 0.432). This evidence concerns the gene ENAH and autoimmune polyendocrinopathy.